Hailey Bieber reveals ‘lonely journey’ with health condition following birth of son Jack Blues

Hailey Bieber has publicly revealed that she experienced PMDD, or premenstrual dysphoric disorder, following the birth of her son, Jack Blues. According to reports from People.com, Page Six, and Yahoo, Bieber described this experience as a lonely journey. The disclosure links her personal health struggles with a broader corporate initiative involving her skincare brand, Rhode, which has announced a significant financial commitment toward the study and improvement of women's health outcomes. Coverage of the announcement is being led by WWD, which provided an exclusive report, alongside reporting from People.com and Cosmetics Business.

These outlets emphasize the dual nature of the news, focusing both on Bieber's personal vulnerability regarding her postpartum health and the concrete action taken by her business. WWD highlights that Rhode is committing $5 million to research, while Cosmetics Business specifies that this funding takes the form of a grant and a formal partnership with the Foundation for Women’s Health. The context of this trend centers on the visibility of PMDD and the intersection of celebrity influence and medical philanthropy. By naming the specific condition she faced after the birth of Jack Blues, Bieber is bringing attention to a particular health struggle that she characterized as isolating.

The timing of the reveal suggests a strategic alignment between her personal history and the philanthropic goals of Rhode, positioning the brand as a supporter of women's health research through its multimillion-dollar contribution. Future developments to monitor include the specific research initiatives funded by the $5 million grant and the operational details of the partnership between Rhode and the Foundation for Women’s Health. Because the funding is designated for research, subsequent reports will likely focus on how the Foundation for Women’s Health allocates these resources. Coverage does not yet specify the exact timeline for the research projects or the specific medical milestones the grant intends to achieve.